美國MEFs Oct4-GFP報告基因小鼠胚胎成纖維細胞
美國PrimCells干細胞：PrimCells提供多種報告基因敲進(jìn)的小鼠胚胎干細胞，該類(lèi)細胞皆在原始基因座上敲入熒光報告基因，從而使熒光蛋白的表達能真實(shí)反映原基因座附近的表達調控狀況。該類(lèi)細胞作為研究胚胎干細胞自更新和定向分化的有力工具，受到多家有名研究所研究人員的青睞。
|
Species:
|
Mus Musculus (129/B6 Mix)
|
Catalog Number:
|
PCEMM03
|
|
Cell Number:
|
~1x106
|
Storage/Shipping:
|
Dry Ice
|
Newly In Stock!
Introduction:
Primary mouse embryonic fibroblasts (MEFs) are typically derived from E13.5 mouse embryos. They are relatively easy to culture and maintain and have robust proliferation rate. MEFs can be powerful tools to study gene functions especially when comparison experiments between wild-type and knockout cells from the same liter are required. Meanwhile, MEFs have also been used as feeder cells to support growth of embryonic stem cells from a variety of species1. More recently, MEFs from reporter transgenic mice were used for assessing gene function during reprogramming of fibroblasts to induced pluripotent stem cells (iPSCs) 2.
PrimCells is proud to isolate and provide the primary cultures of embryonic fibroblasts from transgenic mice carrying IRES-GFP gene in their endogenous Pou5f1 (Oct4) locus. When these cells are fully reprogrammed, iPSCs will become GFP+, which could be a powerful tool for chemical screening or gene functional studies in order to develop more efficient reprogramming technology.
Figure 1 | Successfully reprogrammed iPSCs become GFP positive
美國PrimCells品牌介紹
PrimCells是位于美國加州圣迭戈的一家專(zhuān)業(yè)致力于細胞產(chǎn)品研發(fā)和解決方案提供的業(yè)內技術(shù)領(lǐng)導企業(yè)。
公司匯集了**的生物醫藥技術(shù)專(zhuān)家，獨立開(kāi)發(fā)了多項原代細胞和干細胞相關(guān)的專(zhuān)有技術(shù)。 公司以“細胞研究的選擇”為宗旨，自主研發(fā)超過(guò)70種**產(chǎn)品，填補了多個(gè)特種細胞市場(chǎng)的空白。例如其誘導性表達細胞庫和高效3D皮膚培養系統，皆為該類(lèi)產(chǎn)品目前市場(chǎng)上少數的規?；?。此外，公司以高質(zhì)量的數據與快速穩定的項目完成時(shí)間，長(cháng)期為多家知名制藥公司提供解決方案，獲得用戶(hù)廣泛贊譽(yù)。
PrimCells產(chǎn)品線(xiàn)：
1. 報告基因干細胞 2. 原代細胞（含報告基因原代細胞） 3. 誘導性穩定細胞株
4. 人源重組蛋白 5. **型培養試劑
PrimCells 解決方案
1.誘導性穩定細胞株開(kāi)發(fā) 2. 原代細胞開(kāi)發(fā) 3. **體外毒理和效能測試 4. 3D-皮膚培養
PrimCells合作伙伴及客戶(hù):
A．生物制藥公司：輝瑞(Pfizer), 諾華(Novartis), 禮來(lái)(Eli2 Lilly),. Amgen, EMD Millipore, Regeneron等公司的毒理和醫藥研發(fā)部門(mén)
B．科研機構：冷泉港實(shí)驗室，哈佛醫學(xué)院, 麻省理工（MIT）,， UCSF, NYU, Salk, UIUC, USC等
